Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Amritadi Guggulu is a traditional Ayurvedic polyherbal formulation primarily used in the management of metabolic and inflammatory conditions, most notably gout (Vatarakta), skin diseases, and obesity. The formulation typically centers on Guggulu (*Commiphora mukul*) and Amrita (*Tinospora cordifolia*), combined with other herbs such as Triphala (a mixture of *Emblica officinalis*, *Terminalia bellirica*, and *Terminalia chebula*), Danti (*Baliospermum montanum*), and Vyosha (a combination of black pepper, long pepper, and ginger). It is believed to work by balancing the Vata and Pitta doshas and detoxifying the blood (Rakta-shodhaka). In Ayurvedic practice, it is recognized for its anti-inflammatory, analgesic, and blood-purifying properties. Arlak Ayurveda markets this as a consumer herbal supplement in capsule form.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Amritadi Guggulu.